RPAI: A Protein At The Center of DNA Replication in Bacteria (G22934)

Target Name: RPIA

NCBI ID: G22934

RPIA

RPAI: A Protein At The Center of DNA Replication in Bacteria

Riboriboisome A (RPAI) is a protein that is involved in the process of DNA replication in bacteria. It plays a crucial role in ensuring that the DNA replication is accurate and that the resulting offspring are genetically identical. Mutations in the RPAI gene have been linked to a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, RPAI has become a focus of interest for researchers as a potential drug target or biomarker.

The RPAI gene is located on chromosome 18 and encodes a protein that is composed of 218 amino acids. It belongs to the superfamily of proteins known as the IRIS superfamily and is responsible for the catalytic activity of RPAI. RPAI functions as a RNA polymerase ( RNA polymerase II) enzyme, which means that it uses RNA as the template to synthesize DNA. This process is essential for DNA replication in bacteria and is critical for the maintenance of genetic identity in the population.

RPAI has been shown to play a key role in the regulation of gene expression in bacteria. It has been shown to interact with a number of different proteins, including DnaC, which is a protein that binds to the promoter region of a gene. This interaction between RPAI and DnaC allows RPAI to regulate the activity of gene promoters and determine which genes are expressed in the cell.

In addition to its role in gene expression, RPAI has also been shown to play a critical role in the regulation of DNA replication. It has been shown to interact with the protein DnaB, which is involved in the formation of a double helix during DNA replication . This interaction between RPAI and DnaB allows RPAI to ensure that the double helix is 鈥嬧?媐ormed correctly and that the resulting offspring are genetically identical.

Mutations in the RPAI gene have been linked to a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, studies have shown that individuals with mutations in the RPAI gene are at increased risk of developing cancer. This is because mutations in RPAI have been shown to disrupt the normal function of the DNA replication machinery, leading to the development of cancer.

In addition to its potential as a drug target or biomarker, RPAI has also been shown to be a promising target for research into the mechanisms of gene regulation in bacteria. Studies have shown that RPAI plays a critical role in the regulation of gene expression in bacteria , and that it interacts with a number of different proteins. These interactions provide insight into the mechanisms of gene regulation in bacteria and may have implications for the development of new antibiotics.

Overall, RPAI is a protein that has important roles in the regulation of gene expression and DNA replication in bacteria. Its functions as a RNA polymerase enzyme and its potential as a drug target or biomarker make it an attractive target for research in the field of molecular biology. Further studies are needed to fully understand the mechanisms of RPAI's role in gene regulation in bacteria and to explore its potential as a drug or biomarker.

Protein Name: Ribose 5-phosphate Isomerase A

Functions: Catalyzes the reversible conversion of ribose-5-phosphate to ribulose 5-phosphate and participates in the first step of the non-oxidative branch of the pentose phosphate pathway

The "RPIA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPIA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets